NCT06715553

Brief Summary

The objective of the study is to investigate the effect of interventional program in improving the quality of life for individuals with chronic schizophrenia The design of the study will be an interventional study - Randomized Control Trial - taking place in the Psychiatric hospital of the Cross Lebanon. Six types of intervention will be done on the patients such as ping-pong, sport exercise, psychoeducation program, nutrition, art therapy and bibliotherapy. A 100 patients adhering to the inclusion and exclusion criteria will be randomized into two groups (50 patients in the intervention group and 50 patients in the control group) - Simple Randomization. A Baseline and follow-up assessments will take place at the beginning of the study and after three months through using Arabic Validated Scales. The scales that be used are the following Positive and negative symptoms scale (PANSS), to determine severity of symptoms in patients. WHO quality of life questionnaire WHOQOL- BREF Arabic version: physical, psychological, social and environmental and EQ-5D scale, to determine quality of life of patients. MOCA scale to determine cognitive function, Rosenberg self-esteem questionnaire, Social functioning questionnaire QFS and Birchwood Insight Scale.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 9, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 10, 2025

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

November 13, 2024

Last Update Submit

March 7, 2025

Conditions

Keywords

schizophreniaquality of lifeInterventional programFunctional abilities

Outcome Measures

Primary Outcomes (2)

  • WHO Quality of Life-BREF (WHOQOL-BREF)

    The WHOQOL-BREF measure the subjects' perception of QOL in every domain and the subjects' satisfaction with health and overall rating of QOL. The WHOQOL-BREF is a shortened version of the WHOQOL-100, it is composed of 26 items that uses a 5 point response scale ranging from 1 (very dissatisfied/very poor) to 5 (very satisfied/very good). Four domains were addressed including the physical health (seven items, Q3, Q4, Q10, Q15, Q16, Q17, Q18), psychological health (six items, Q5, Q6, Q7, Q11, Q19, Q26), social relations (three items, Q20, Q21, Q22), and environment (eight items, Q8, Q9, Q12, Q13, Q14, Q23, Q24, Q25). Domain scores are scaled in a positive direction (i.e. higher scores denote higher quality of life) with elevated score indicating higher quality of life. The mean score of items within each domain is used to calculate the domain score. Mean scores are then multiplied by 4 in order to make domain scores comparable with the scores used in the WHOQOL-100.

    three months

  • The 5-level EQ-5D version (EQ-5D-5L)

    The 5-level EQ-5D version (EQ-5D-5L) questionnaire is a globally used and multiply validated tool to assess health-related quality of life (HRQoL). It consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

    Three months

Secondary Outcomes (2)

  • Global Assessment of Functioning (GAF)

    three months

  • Questionnaire du focntionnement sociale (QFS)

    three months

Other Outcomes (1)

  • Clinical symptoms

    three months

Study Arms (2)

Interventional group

EXPERIMENTAL

Participants will be randomly assigned to the intervention group Six types of intervention will be done on the patients as follows: * Psychoeducational intervention program prepared and will be applied by a psychologist * Art therapy program will be done by a psychologist * Bibliotherapy program will be done by a neuroscience person * Nutrition program will be done a nutritionist * Sport activity will be held by a physical trainee * Ping Pong activity will be done by a ping pong trainer

Behavioral: BALANCE Program (Body, Art, Learning, Activities, Nutrition, Creativity, and Education)

Control Group

NO INTERVENTION

This group will follow the standard care provided by the hospital without any type of intervention

Interventions

Six types of intervention will be done on the patients as follows: * Psychoeducational intervention program * Art therapy program * Bibliotherapy program * Nutrition program * Sport activity * Ping Pong activity

Interventional group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals diagnosed with chronic schizophrenia according to DSM-V criteria
  • Aged 18-65.
  • Physically capable of participating in physical
  • Clinically stable

You may not qualify if:

  • Active substance use
  • Severe cognitive impairment
  • Intellectual disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychiatric Hospital of the Cross

Beirut, Lebanon

Location

Related Publications (4)

  • Deenik J, Tenback DE, van Driel HF, Tak ECPM, Hendriksen IJM, van Harten PN. Less Medication Use in Inpatients With Severe Mental Illness Receiving a Multidisciplinary Lifestyle Enhancing Treatment. The MULTI Study III. Front Psychiatry. 2018 Dec 18;9:707. doi: 10.3389/fpsyt.2018.00707. eCollection 2018.

    PMID: 30618878BACKGROUND
  • Effect of psycho-educational intervention on drug adherence and quality of life among patients with Schizophrenia in Jigawa State, Nigeria

    BACKGROUND
  • Hjorth P, Medici CR, Juel A, Madsen NJ, Vandborg K, Munk-Jorgensen P. Improving quality of life and physical health in patients with schizophrenia: A 30-month program carried out in a real-life setting. Int J Soc Psychiatry. 2017 Jun;63(4):287-296. doi: 10.1177/0020764017702172. Epub 2017 Apr 3.

    PMID: 28367717BACKGROUND
  • Kang R, Wu Y, Li Z, Jiang J, Gao Q, Yu Y, Gao K, Yan Y, He Y. Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study. Psychopathology. 2016;49(5):345-355. doi: 10.1159/000448195. Epub 2016 Sep 2.

    PMID: 27584836BACKGROUND

Related Links

MeSH Terms

Conditions

Schizophrenia

Interventions

Reproductive Techniques, AssistedEducational StatusExerciseNutritional Status

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Reproductive TechniquesTherapeuticsInvestigative TechniquesSocioeconomic FactorsPopulation CharacteristicsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemography

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A 86 patients adhering to the inclusion and exclusion criteria will be randomized into two groups (43 patients in the intervention group and 43 patients in the control group) and the interventional model type will be in Parallel.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Family medicine specialist

Study Record Dates

First Submitted

November 13, 2024

First Posted

December 4, 2024

Study Start

August 9, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 10, 2025

Record last verified: 2024-12

Locations